Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2025
Archives
Bone marrow transplantation and haplotyping
Brian Tait, chief scientific officer, Haplomic Technologies Pty Ltd, explores the clinical benefits of haplotyping in single-chromosome sequencing and unrelated donor bone marrow transplantation (HSCT).
The promise of antimicrobial peptides
Brian P. Lazzaro, Liberty Hyde Bailey Professor at Cornell University, highlights the promise of antimicrobial peptides (AMPs) as powerful agents in the ongoing battle against antibiotic resistance.
3D microscopic whole brain neurodegenerative MRI
This article by G. Allan Johnson, Ph.D., focuses on advanced MRI techniques for studying neurodegenerative diseases, exploring the challenges of screening therapies for conditions like Alzheimer’s and Parkinson’s, and highlighting the promising research conducted at Duke University.
Cancer care through molecular diagnostics: Addressing papillary thyroid cancer
Oliver Bathe from the University of Calgary and Qualisure Diagnostics, walks us through addressing the surge in papillary thyroid cancer incidence by refining cancer care through molecular diagnostics.
Proceedings of the Libby, Montana asbestos education & outreach retreat
Jean C. Pfau discusses the history and health implications of the vermiculite mine in Libby, Montana, and the establishment of the Center for Asbestos-Related Disease (CARD), which offers vital clinical services for affected individuals. Additionally, a retreat in June 2025 allowed experts to share research findings on asbestos exposure.
Ovarian phenotypes impact fertility and pregnancy outcomes
In this ovarian health focus, Adjunct Assistant Professor Zhongwei Huang, Dr. Paula Benny and Ms. Hui Wen Tam explore how ovarian phenotypes affect ovarian function and lifespan, leading to complications in pregnancy outcomes.
What can we learn from millions of viral genome sequences?
David Ussery and Pratul Agarwal, Professors in the Department of Physiological Sciences at Oklahoma State University, discuss their work using high-performance computing for the analysis of millions of viral genome sequences.
Advancing value-based healthcare (VBHC) through collaborative innovation
The UK NHS’s are all seeking sustainable, outcomes-driven care, adopting VBHC with its focus on better patients outcomes relative to cost: an approach underpinning the recent 10 year plan for England. A joint project between an International Biopharmaceutical Company and Swansea University explored effective collaboration for successful VBHC implementation.
Confirming Electromagnetic Hypersensitivity (EHS)
Michael Bevington of Electrosensitivity UK advocates for recognising the health and environmental impacts of human-made electromagnetic fields (EMFs), citing both historical and legal acknowledgement as well as scientific research linking EMFs to various symptoms.
ProteCoat™: Non-toxic antimicrobial coating for safer hospitals and public spaces
ProteCoat™ is a non-toxic antimicrobial coating technology developed by Reactive Surfaces aimed at reducing healthcare-associated infections (HAIs) in hospitals and public spaces.
The prepared code: A values-driven approach to pandemic preparedness
Corinna Pannofino, Research Communications Manager at Trilateral Research, introduces a new framework for ethical research that was launched to prepare for the next pandemic, restoring public trust and ensuring scientific integrity.
Lighting the way to cancer surgery
By decoding the subtle timing of light, scientists could give surgeons sharper vision in the operating room – and patients a brighter outlook beyond it.
The next chapter in regenerative medicine for osteoarthritis: From real-world evidence to regulatory shifts
Osteoarthritis (OA) remains one of the leading causes of disability worldwide, yet the therapeutic landscape is evolving faster than ever.
Personalizing wellbeing interventions in the digital era
Troy W. Norris’ WellBalance Institute is advancing the science of positive psychology and wellbeing to create personalized plans and practical tools to build happy, flourishing, and resilient lives, workplaces, and communities
Rational use of psychotropic medications in youth
This article examines a holistic approach to youth mental health care and discusses the concept of ‘deprescribing’ as a systematic method for assessing the necessity and risks associated with the continued use of medication.
Revolutionising global vaccine access: The case for Stablepharma’s fridge-free vaccine technology
Stablepharma is focused on improving global vaccine access with its leading candidate, SPVX02. Here, they discuss the challenges of vaccine development and distribution, and highlight how their platform could transform accessibility through fridge-free vaccines.
The oncoming tsunami of RNA therapeutics
Alan Herbert, Founder and President of InsideOutBio, discusses the significant advancements in RNA therapeutics, highlighting their role in supporting public health and their transformative potential in modern medicine, particularly for addressing genetic conditions and cancer.
Prevention of eating disorders with single session interventions: Hype or promise?
Is reducing the risk of eating disorders with single session interventions a hype or a promise? Tracey Wade at the Flinders University Institute for Mental Health and Wellbeing investigates.
Enabling preventive medicine and improving patient care via aptamer-based molecular monitors
As health systems put greater focus on preventive, personalized care, Netzahualcóyotl Arroyo-Currás tells us about the broad benefits of Continuous Molecular Monitors (CMMs) in providing insights into biomolecular markers that facilitate early disease detection.
Protecting infants from brain damage: A focus on HIE
Lee J. Martin, PhD from Johns Hopkins University School of Medicine, discusses the pathology of infant hypoxic-ischemic encephalopathy (HIE), and the research he and his team are conducting to understand cell death mechanisms related to HIE and therefore identify new therapies.
